Subscribe


Pharmacy Daily

PD breaking news – API profit surges 27%

$29.1 million net profit after tax for the six months to 28 February. 

Australian Pharmaceutical Industries has just released its first half results, with reported net profit after tax up 27.2% on the previous corresponding period. However that included a $2.4m loss on the company’s sale of its shareholding in CH2, so the “underlying improvement” was 15%. Total revenue was up 12.7% to just over $2 billion for the period.

API ceo Richard Vincent said the Priceline Pharmacy network expanded to 450 stores, with 25 added during the last twelve months. Total retail network register sales rose 7.2% including strong growth in dispensary, while comparable store sales were up 0.4%. He said Priceline gained market share in dispensary, skincare, OTC health and colour cosmetic segments.

“The strength of the Priceline Pharmacy brand continues to attract independent pharmacists to our network and the pipeline of potential partners remains robust,” Vincent said. API expects to add at least 20 additional Priceline Pharmacy stores during the current financial year, boosting the network to 462. 

The company’s pharmacy distribution revenues were up 18% due to the new high-value hepatitis C medicines. Removing this effect and the impacts of PBS reform, the underlying growth was 5.9%.

The API board declared a fully franked interim dividend of 3.5c per share, an increase of 40%.

Vincent said the company anticipated that consumer sentiment is likely to remain more challenging than in previous years. “However we remain confident in our retail store pipeline and in reducing operational costs,” he said, with API expecting another year of record full year net profit after tax.

More details in tomorrow’s issue of Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 20 Apr 17

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

20 Sep

Dermal Therapy Very Dry Skin Lotion - DERMAL Therapy Very Dry Skin Lotion is ...


20 Sep

Sensitive SPF 50+ Sunscreen - TO cater for those with sensitive skin, ...


20 Sep

Clinical Protection Anti-Perspirant Deodorant by Dove - DOVE Clinical Protection Anti-Perspirant Deodorant combines clinical ...


20 Sep

Hello Brows 2-in-1 Stylus by Ulta3 - ULTA3 Hello Brows 2-in-1 Stylus is a ...


20 Sep

Dispensary Corner 20 Sep 17 - TALK about flush with cash - Geneva ...


20 Sep

Medlab 20 year patent - AUSTRALIAN-LISTED medical life science company Medlab Clinical ...


20 Sep

TGA clamps down on unapproved goods - THE Therapeutic Goods Administration (TGA) has announced ...


20 Sep

Butterfly given wings - THE Butterfly Foundation, which supports people with ...


20 Sep

World Pharmacists Day competition - THE 25th of September is World Pharmacist ...


20 Sep

Beta-blockers blocked - HEART attack sufferers over the age of ...


20 Sep

Dispensing sans script - NEW Zealand pharmacists will now be able ...


20 Sep

Epilepsy in Medadvisor - ASX-LISTED digital medication management company, MedAdvisor, has ...


20 Sep

OTC codeine misuse costs - SERIOUS misuse of OTC painkillers containing codeine ...


19 Sep

Guild Update 19 Sep 17: Making the most of vaccination services - THE Pharmacy Guild has developed a Vaccination ...


19 Sep

Dispensary Corner 19 Sep 17 - THE drinking of alcohol in the bewitching ...


19 Sep

Parkinson’s live study - RESEARCH teams at the South Australian Health ...


19 Sep

ADEs from dispensing - ADVERSE drug events (ADEs) and medication errors ...


19 Sep

Top Aussie firms - THE Australian Financial Review has published its ...


19 Sep

Real-world evidence improves adherence - REAL-WORLD evidence (RWE) - that is to ...


19 Sep

One stop vax shot - A RESEARCH team at Massachusetts Institute of ...



Show Pharmacy Daily items by month: